
|Articles|April 1, 2004
The American Journal of Managed Care
- April 2004
- Volume 10
- Issue 4
Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Improving Patient-Centered Cardiovascular Care for Older Adults
3
Mitigate Treatment Burden in Heart Failure: Martha Gulati, MD
4
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
5















































